Le Lézard
Classified in: Covid-19 virus
Subjects: Photo/Multimedia, Product/Service

ExchangeRight Affiliate Telos Capital Achieves Over 11% Investor Annual IRR with RV Resort Development


ExchangeRight's sister company Telos Capital, a private equity real estate investment company that focuses on value-add and development real estate investments across all asset classes and sectors, has brought its TCF2 Stella Mare investment full cycle on behalf of its investors. The property generated total returns including distributions during the hold period of over 168% of originally invested equity, with a net investor annual internal rate of return of over 11% annualized.

In 2015 Telos partnered with an experienced JV operator to identify and develop a best-in-class RV Resort, leading to the investment in an approximately 25-acre parcel in Galveston, Texas. The investment opened in under a year and saw its performance consistently improve year-over-year even throughout the COVID-19 crisis.

"We are proud of how our team proactively managed our TCF2 asset to optimize investor value and ensure a successful full cycle outcome," said Joshua Ungerecht, a managing partner of Telos and ExchangeRight. "We are pleased that we were able to execute a profitable exit on behalf of investors in the face of multiple hurricanes, the COVID-19 crisis, government shutdowns, and increased competition. We remain committed to protecting and growing the wealth of those who entrust us with their capital, and we are grateful for the investors, representatives, and advisors who chose to invest with our vertically integrated platform."

About Telos Capital

Telos Capital targets discounted, value-add, or opportunistic private real estate investments across all asset classes and sectors. The principals of Telos invest side-by-side with investors and are generally the largest investors in the company's projects. Telos is affiliated with ExchangeRight, one of the nation's largest 1031 DST sponsors. Please visit www.teloscapitalfunds.com for more information.

About ExchangeRight

ExchangeRight pursues its passion to empower people to be secure, free, and generous by providing REIT, fund, and 1031 DST portfolios that target secure capital, stable income, and strategic exits. The company strategically syndicates net-leased portfolios of assets backed primarily by investment-grade corporations that successfully operate in the necessity-based retail and healthcare industries, as well as diversified value-add portfolios of inline and outparcel retail spaces shadow-anchored by strong-performing grocery tenants. Please visit www.exchangeright.com for more information.


These press releases may also interest you

27 nov 2021
Petroteq Energy Inc. ("Petroteq" or the "Company") ‎‎(‎OTC PINK:PQEFF), an oil ‎company focused on the development and implementation of its proprietary oil-‎extraction and remediation technologies,...

27 nov 2021
With the emergence in South Africa of yet another potentially more dangerous COVID-19 strain, AIDS Healthcare Foundation (AHF) echoes President Biden's recent appeal for wealthy countries to step up the sharing of their excess vaccines and to back...

27 nov 2021
BlueVine, the leading provider of innovative financial services for small businesses, today announced the launch of its Small Business Resilience Program, which is designed to celebrate small businesses that exhibited exceptional leadership,...

27 nov 2021
Robbins Geller Rudman & Dowd LLP announces that purchasers of Novavax, Inc. securities between March 2, 2021 and October 19, 2021, inclusive (the "Class Period") have until January 11, 2022 to seek appointment as lead plaintiff in Sinnathurai v....

27 nov 2021
On November 23rd, EICMA has opened grandly. It brings thousands of well-known two-wheeler enterprises around the world together to showcase products. Among them, the "China Brand Fair" composed of ARIIC, CFMOTO, CYCLONE, DAYNG, DAYUN, QJMOTOR, SENKE,...

27 nov 2021
Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof. Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) on November 26, the 2020...



News published on 28 october 2021 at 09:15 and distributed by: